Beyond Air to Join Piper Sandler Healthcare Conference
14 Nov 2024 //
GLOBENEWSWIRE
Beyond Air Reports Fiscal Q2 2025 Financial Results & Update
11 Nov 2024 //
GLOBENEWSWIRE
Beyond Air® Schedules Q2 2025 Results Call and Webcast
29 Oct 2024 //
GLOBENEWSWIRE
Beyond Air Partners to Expand LungFit® PH Access
02 Oct 2024 //
GLOBENEWSWIRE
Beyond Air Announces $20.6 Million Private Placement Offering
27 Sep 2024 //
GLOBENEWSWIRE
Beyond Air Announces Termination Of Loan And Security Agreements
27 Sep 2024 //
GLOBENEWSWIRE
Beyond Air Provides LungFit PH System To U.S. Naval Hospital Guam
27 Sep 2024 //
GLOBENEWSWIRE
Beyond Air To Join ROTH Healthcare Opportunities Conference
23 Sep 2024 //
GLOBENEWSWIRE
Beyond Air Reports Q1 2025 Results And Provides Corporate Update
06 Aug 2024 //
GLOBENEWSWIRE
Beyond Air Publishes Data On Nitric Oxide For Viral Pneumonia
31 Jul 2024 //
GLOBENEWSWIRE
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
23 Jul 2024 //
GLOBENEWSWIRE
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
16 Jul 2024 //
GLOBENEWSWIRE
Beyond Air® Reports Q4 And Full Year 2024 Financial Results, Corporate Update
24 Jun 2024 //
GLOBENEWSWIRE
Beyond Air Fy2024 Results Call: Schedules Financials Webcast Announced
23 May 2024 //
GLOBENEWSWIRE
Beyond Air® Announces Pricing of $16.0M RDO of Common Stock and Warrants
20 Mar 2024 //
GLOBENEWSWIRE
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
12 Feb 2024 //
GLOBENEWSWIRE
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results
18 Jan 2024 //
GLOBENEWSWIRE
Beyond Cancer Phase 1 Study Clears Cohort 1 in Patients with Solid Tumors
27 Dec 2023 //
GLOBENEWSWIRE
Beyond Air To Participate in the 35th Annual Piper Sandler Healthcare Conference
15 Nov 2023 //
GLOBENEWSWIRE
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
13 Nov 2023 //
GLOBENEWSWIRE
Beyond Cancer Presents Positive First-in-Human Data for UNO Therapy in Tumors
03 Nov 2023 //
GLOBENEWSWIRE
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference
19 Oct 2023 //
GLOBENEWSWIRE
Beyond Air® To Participate in the Truist Securities BioPharma Symposium
17 Oct 2023 //
GLOBENEWSWIRE
Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH
16 Oct 2023 //
GLOBENEWSWIRE
Beyond Cancer Presents Positive Data for UNO with Checkpoint Inhibitor Therapy
16 Oct 2023 //
GLOBENEWSWIRE
Beyond Cancer Selected to Present Posters Discussing Data from the UNO Therapy
04 Oct 2023 //
GLOBENEWSWIRE
Beyond Air® To Participate in Roth MKM 2023 Healthcare Opportunities Conference
02 Oct 2023 //
GLOBENEWSWIRE
Beyond Cancer to Present Data for Ultra-High Concentration Nitric Oxide Therapy
27 Sep 2023 //
GLOBENEWSWIRE
Beyond Air Announces Publication of Data for Autism Spectrum Disorder
18 Sep 2023 //
GLOBENEWSWIRE
Beyond Air® and Getz Healthcare Enter Strategic Collaboration
07 Sep 2023 //
GLOBENEWSWIRE
Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference
06 Sep 2023 //
GLOBENEWSWIRE
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024
10 Aug 2023 //
GLOBENEWSWIRE
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in ASD
07 Aug 2023 //
GLOBENEWSWIRE
Beyond Air® To Participate in BTIG™s 2023 Virtual Biotechnology Conference
01 Aug 2023 //
GLOBENEWSWIRE
Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference
24 Jul 2023 //
GLOBENEWSWIRE
Beyond Air® Reports Financial Results for 4Q and Fiscal Year-End 2023
22 Jun 2023 //
GLOBENEWSWIRE
Beyond Air looks beyond lungs to target nitric oxide in autism
20 Jun 2023 //
FIERCE BIOTECH
Beyond Air® Licenses Commercial Rights to Selective Neuronal (nNOS)
15 Jun 2023 //
GLOBENEWSWIRE
Beyond Air® Secures up to $40 Million Debt Financing
15 Jun 2023 //
GLOBENEWSWIRE
Beyond Air Schedules Fiscal Year End 2023 FYR Conference Call and Webcast
16 May 2023 //
GLOBENEWSWIRE
Beyond Air Appoints Jeff Myers, M.D. Ph.D. as Chief Medical Officer
23 Mar 2023 //
GLOBENEWSWIRE
Beyond Cancer to Present for Ultra-High Concentration Nitric Oxide Therapy
14 Mar 2023 //
GLOBENEWSWIRE
Beyond Air Announces Participation at Two Investor Conferences in March 2023
22 Feb 2023 //
GLOBENEWSWIRE
Beyond Air Reports Financial Results for the Third Quarter of Fiscal Year 2023
09 Feb 2023 //
GLOBENEWSWIRE
Beyond Cancer Appoints Gavin Choy, PharmD as Chief Operating Officer
30 Jan 2023 //
GLOBENEWSWIRE
Beyond Cancer Announces Sponsored Research Agreement with Stanford
24 Jan 2023 //
GLOBENEWSWIRE
Beyond Air Schedules Third Fiscal Quarter 2023 Financial Results Conference
17 Jan 2023 //
GLOBENEWSWIRE
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023
08 Nov 2022 //
GLOBENEWSWIRE
Beyond Air Announces Positive Data for Inhaled Nitric Oxide (NO)
24 Oct 2022 //
GLOBENEWSWIRE
Beyond Air Schedules Q2 2023 Financial Results Conference Call and Webcast
20 Oct 2022 //
GLOBENEWSWIRE
Beyond Air® Announces +VE Data from At-Home Pilot Study with Refractory NTM
17 Oct 2022 //
GLOBENEWSWIRE
Beyond Air® To Participate in Three Upcoming Investor Conferences
16 Sep 2022 //
GLOBENEWSWIRE
Beyond Air Schedules First Fiscal Quarter 2023 Financial Results Conference Call
27 Jul 2022 //
GLOBENEWSWIRE
Beyond Air`s LungFit PH Receives FDA Approval for Hypoxic Respiratory Failure
28 Jun 2022 //
GLOBENEWSWIRE
Beyond Air Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
28 Jun 2022 //
GLOBENEWSWIRE
Beyond Air Announces FY End 2022 Financial Results Conference Call
14 Jun 2022 //
GLOBENEWSWIRE
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer
17 May 2022 //
GLOBENEWSWIRE
Beyond Air Presents Positive Study Update from At-Home LungFit GO Pilot Study
17 May 2022 //
GLOBENEWSWIRE
Beyond Air Schedules Fiscal Year 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE